REMAP ECMO - Beta Receptor Modulation Trial

Clinical trial NCT06522594 · UNKNOWN

Trial details

NCT number: NCT06522594
Sponsor: Erasmus Medical Center
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Heart Failure Cardiogenic Shock

Start date: 2024-06-01
Primary completion: 2025-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.